NCT02005458 2018-07-17
Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy
Xiamen Amoytop Biotech Co., Ltd.
Phase 2 Completed
Clinical Trials
1 trialsPhase 2 × Carcinoma, Non-Small-Cell Lung × pegylated granulocyte colony-stimulating factor × Clear all